Jefferies Financial Group Inc. Astrazeneca PLC Put Options Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $3.07 Million - $3.5 Million	40,000 New	40,000 $3.12 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $8.98 Million - $9.73 Million	-128,400 Reduced 61.91%	79,000 $5.65 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $10.3 Million - $11.6 Million	162,400 Added 360.89%	207,400 $14.4 Million
Q4 2022 Sep 21, 2023	SELL	$54.21 - $70.44 $1.84 Million - $2.39 Million	-34,000 Reduced 43.04%	45,000 $3.05 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $2.44 Million - $3.17 Million	45,000 New	45,000 $3.05 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.